https://www.marketscreener.com/quote/stock/ROCHE-HOLDING-AG-68997/news/Roche-Hemlibra-reduced-treated-bleeds-by-96-percent-compared-to-no-prophylaxis-in-phase-III-HAVEN-26624667/?utm_source=telegram&utm_medium=social&utm_campaign=share